Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 6.26
-0.12 (-1.88%)
Jul 11, 2025, 3:19 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €175.28 million as of July 11, 2025. Its market cap has decreased by -46.50% in one year.
Market Cap
175.28M
Enterprise Value
152.95M
Revenue
9.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.26
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 175.28M, a decrease of -28.37%. That is a compound annual growth rate of -6.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 175.28M | -4.28% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 32.80B |
| argenx SE | 29.41B |
| Financière de Tubize | 6.05B |
| Fagron NV | 1.60B |
| Ion Beam Applications | 343.01M |
| Nyxoah | 247.82M |
| Onward Medical | 202.47M |
| Sequana Medical NV | 77.62M |